News & Updates

Colorectal cancer alters gut microbiome
Colorectal cancer alters gut microbiome
24 Jun 2022 byTristan Manalac

Patients with colorectal cancer (CRC) have a substantially altered gut microbiome, characterized by changes in bacterial composition, according to a recent Singapore study. Of note, these alterations persist even after surgery.

Colorectal cancer alters gut microbiome
24 Jun 2022
Baricitinib delays, lowers frequency of flares in JIA
Baricitinib delays, lowers frequency of flares in JIA
23 Jun 2022 byRoshini Claire Anthony

In patients with juvenile idiopathic arthritis (JIA) with insufficient response to conventional synthetic (cs) or biologic (b) disease-modifying antirheumatic drugs (DMARDs), the JAK*1/2 selective inhibitor baricitinib reduced the frequency and delayed time to disease flares, according to a phase III trial presented at EULAR 2022.

Baricitinib delays, lowers frequency of flares in JIA
23 Jun 2022
Negative transrectal ultrasound biopsy tied to low prostate cancer death
Negative transrectal ultrasound biopsy tied to low prostate cancer death
23 Jun 2022

Prostate cancer-specific mortality is very low among men with negative transrectal ultrasound (TRUS) biopsies, particularly those with prostate-specific antigen (PSA) <10 ng/ml, reports a study.

Negative transrectal ultrasound biopsy tied to low prostate cancer death
23 Jun 2022